IP Library Granted Patent US 9,883,986
Granted Patent B2
US 9,883,986 · App. 14/155,420 · Granted Feb 6, 2018

Standing bag type infusion liquid container

Inventors: Shota Mochizuki (Shizuoka, JP); Naoki Morinaka (Shizuoka, JP)
Assignee: EA Pharma Co., Ltd.
A61J1/10A61J1/1462A61J1/1493B65B3/003B65B55/022A61J2200/76A61M1/1601A61M2025/0059A61M2205/3334F04C2270/0421
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,883,986
App. No.
14/155,420
Granted
Feb 6, 2018
Kind
B2
Abstract

The present invention relates to a standing bag type container and aims to increase a visibility of the residual liquid volume in accordance with the progress of infusion process. The standing bag type container includes a bag 10 made of soft resin films and forming at its one end a base member 20 and an outlet port 18 at the other end of the bag. A suspension of the bag 10 is done in a manner that the base member 20 is located at the top. Marks for indication of residual liquid volume are printed on the surface of the bag. An infusion liquid is charged to the bag while an air gap 109 ′ is left, so that a residual liquid volume is verified from the liquid level. Under the suspended condition, the base member 20 has a value of width which is unchanged from the when the bag is under upright condition. The base member 20 is not collapsed and maintains its width even when the residual liquid volume is zero. A portion of the bag of a predetermined height from the top edge of the bag including the base member 20 maintains its shape without being collapsed by a discharge of the liquid.

Claims (19)

1. A standing infusion liquid container comprising:

a squeezable bag configured to store therein an infusion liquid, the squeezable bag being a flat pouch of a welded structure formed from film sheets cut from a continuous raw flexible sheet made from a resin material and having a first end configured to function as a base member;

a suspension member configured to suspend the squeezable bag so that the base member is located at a top of the standing infusion liquid container;

an outlet port for the infusion liquid at a second end of the squeezable bag; and

indication marks for a visual indication of a volume of a residual liquid, the indication marks being formed on a surface of the squeezable bag,

wherein the infusion liquid is filled in the squeezable bag such that an air space is left therein and such that the volume of the residual liquid is visible on a liquid level basis relative to the indication marks,

wherein the base member of the squeezable bag, under a suspended condition by the suspension member, has a value of width, which is equal to a value of the width of the base member under a standing condition of the squeezable bag, and

wherein, in the suspended condition where the squeezable bag is suspended by the suspension member, the base member maintains the value of width without being collapsed regardless of discharge of the infusion liquid, and the base member operates such that opposed sidewalls of the squeezable bag, formed of the film sheets, at any location below the base member are prevented from coming into contact with each other along an entire process of infusion, thereby obtaining a desired indication of gradually reduced level of infusion liquid remaining in the squeezable bag by the indication marks throughout the infusion process.

2. The standing infusion liquid container according to claim 1 , wherein a portion of the squeezable bag including the base member in a part of the squeezable bag a predetermined height from the first end of the squeezable bag constructs a shape retainer to retain a width of the part of the squeezable bag by preventing the part of the squeezable bag from being collapsed regardless the discharge of the infusion liquid from the squeezable bag.

3. The standing infusion liquid container according to claim 1 , wherein the suspension member is formed as an opening on a first side of the squeezable bag, at the first end, and said indication marks are formed on a second side of the squeezable bag opposite the first side.

4. The standing infusion liquid container according to claim 1 ,

wherein the resin material for the film sheets constructing the squeezable bag is polyethylene resin,

wherein a raw polyethylene film of the film sheets has a value of thickness in a range between 180 and 350 μm, and

wherein a polyethylene film of the film sheets as constructed to the squeezable bag has a value of 1% elastic modulus in tension in a range between 150 and 320 Mpa.

5. The standing infusion liquid container according to claim 1 , wherein an inactive gas is mixed with the air inside the squeezable bag.

6. The standing infusion liquid container according to claim 1 , wherein, in a side view of the a squeezable bag, in the suspended condition where the squeezable bag is suspended by the suspension member, the value of the width of the base member is greater than any other width of the squeezable bag below the base member.

7. The standing infusion liquid container according to claim 1 , wherein the base member includes a strip or a plate configured to operate as a strut to prevent the opposed sidewalls of the squeezable bag from coming into contact with each other along an entire process of infusion.

8. The standing infusion liquid container according to claim 1 , wherein, in a front view of the squeezable bag, in a standing condition where the squeezable bag stands upright via the base member a bottom of the standing infusion liquid container, the base member has a curved shape with a lowest height at a center.

9. The standing infusion liquid container according to claim 1 , wherein, in a side view of the squeezable bag, in the suspended condition where the squeezable bag is suspended by the suspension member, the base member has an upwardly convex shape.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2018
From: EA PHARMA CO., LTD.
To: AY PHARMACEUTICALS CO., LTD.
Reel/Frame 046886/0253 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2016
From: AJINOMOTO CO., INC.
To: EA PHARMA CO., LTD.
Reel/Frame 039094/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2014
From: MOCHIZUKI, SHOTA; MORINAKA, NAOKI
To: AJINOMOTO CO., INC.
Reel/Frame 032325/0325 →
Priority Claims (1)
JP 2011-223843 · Oct 11, 2011 · national
Continuity (2)
Continuation PCTJP2012076268 · Oct 11, 2012
Related Publication 20140126843A1 · May 8, 2014